Skip to main content
ISTH 2023 Main banner
Back

    Margaret V. Ragni, MD, MPH (she/her/hers)

    Professor of Medicine and Clinical and Translational Science
    Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Pittsburgh, Pennsylvania, United States

    Margaret V. Ragni, M.D., M.P.H. is a Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh, involved in clinical care and cutting edge clinical translational research in congenital hemostatic and thrombotic disorders. She has served as the chair of clinical trials, prospective epidemiologic, observational, case-control studies, cost-effectiveness analyses, and investigator-initiated new drug trials in hemophilia and VWD. Her studies were among the first multi-center NIH-funded investigator-initiated studies in hemophilia and VWD. Recent studies include the NHLBI-funded multi-center VWDMin Trial to minimize HMB; the HRSA-funded INHIBIT Registry; and the Takeda-funded Investigator-Initiated VWD-Woman Trial to prevent postpartum hemorrhage. She serves as Co-Chair for the 2022 NHF National Research Blueprint Infrastructure Working Group, and was past Co-Chair of the NHF Resources Working Group, and 2018 Subcommittee Co-Chair of the 2018 NHLBI State of the Science NHLBI SOS to design clinical trials for individuals with bleeding disorders. She is the Medical Director of the Hemophilia Center of Western PA and served as a 30-year member of the National Hemophilia Foundation Medical & Scientific Advisory Committee (MASAC). She serves as an Associate Editor of the ASH online journal Blood Advances; as a member of the ASH Maternal Health in Hematology Committee, and serves as a mentor to students, residents, and fellows in clinical translational research.

    Presentation(s):